We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BBAGF market cap is 2.07B. The company's latest EPS is CHF -3.7670 and P/E is -10.03.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 728.17M | 741.78M | 4k | 1.26M | 530k |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 677.43M | 691.17M | -404.81M | -357.81M | -206.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 3.55B | 3.96B | 3.64B | 3.05B | 2.64B |
| Total Liabilities | 161.59M | 75.59M | 360.59M | 367.25M | 313.94M |
| Total Equity | 3.39B | 3.89B | 3.28B | 2.69B | 2.32B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | 215.02M | 262.45M | -94.79M | 231.13M | 218.28M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -205.21M | -284.48M | 91.77M | -233.27M | -220.21M |
| Market Cap | 2.07B |
| Price to Earnings Ratio | -10.03 |
| Price to Sales Ratio | 3.9k |
| Price to Cash Ratio | 4.15k |
| Price to Book Ratio | 0.89 |
| Dividend Yield | - |
| Shares Outstanding | 54.85M |
| Average Volume (1 week) | 50 |
| Average Volume (1 Month) | 438 |
| 52 Week Change | -34.51% |
| 52 Week High | 57.70 |
| 52 Week Low | 37.79 |
| Spread (Intraday) | 8.1 (18.49%) |
| Company Name | BB Biotech AG (PK) |
| Address |
seestrasse 16 kuesnacht 8700 |
| Website | https://www.bbbiotech.com |
| Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
